Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses
doi: 10.1038/s41598-020-74678-6 6 TremblayJHametP
Tirzepatide Tirzepatide is a peptide designed for effective weight management
In clinical trials: Semaglutide: Approximately 7% discontinued due to adverse events Tirzepatide: Approximately 4-7% discontinued due to adverse events (dose dependent) Retatrutide: Approximately 6-10% discontinued due to adverse events (dose dependent) These rates are relatively close, suggesting that despite the differences in mechanism and side effect profiles, all three medications are tolerable for the vast majority of people who start them
It's important to note that if you experience symptoms of diabetic ketoacidosis (excessive thirst, frequent urination, nausea, abdominal pain, confusion, unusual fatigue, or fruity-smelling breath), seek immediate medical attention, particularly if you are also taking an SGLT2 inhibitor medication
